elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q37995087-CD1D7B6D-C137-41B9-AA4A-1D638362A8CB
Q37995087-CD1D7B6D-C137-41B9-AA4A-1D638362A8CB
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37995087-CD1D7B6D-C137-41B9-AA4A-1D638362A8CB
Fragment informatics and computational fragment-based drug design: an overview and update.
P2860
Q37995087-CD1D7B6D-C137-41B9-AA4A-1D638362A8CB
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37995087-CD1D7B6D-C137-41B9-AA4A-1D638362A8CB
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
37f56eade237ab046058eb11cd81324a68ddc880
P2860
Fragment-based drug design and drug repositioning using multiple ligand simultaneous docking (MLSD): identifying celecoxib and template compounds as novel inhibitors of signal transducer and activator of transcription 3 (STAT3).